Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's di…
Biotechnology
US, Berwyn [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Annovis Bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAnnovis Bio, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Annovis Bio, Inc..
If you want to see a demo, head over to the financial segments of AAPL